CBT-I plus Melatonin 3 mg: Clinical Trials

1 trial of CBT-I plus Melatonin 3 mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1
Phase 31Unknown 1

Follow CBT-I plus Melatonin 3 mg: new trials by email Literature Review of CBT-I plus Melatonin 3 mg trials Research Report on CBT-I plus Melatonin 3 mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Melatonin 3mg and 5mg Compared to Cognitive Behavioral Therapy for Insomnia (CBT-I) in the Treatment of Insomnia
CBT-I plus placebo, CBT-I plus Melatonin 3 mg, CBT-I plus Melatonin 5 mg - Insomnia Disorder
Phase 2 / Phase 3UnknownAche Laboratorios Farmaceuticos S.A.3072018-03-222020-09-03

Conditions studied

Sleep Initiation and Maintenance Disorders (1)

Sponsors

Ache Laboratorios Farmaceuticos S.A. (1)

Countries

Brazil (1)

Top investigators

Mauro Crippa Jr. (1)